New Search

Your search found 49 records, sorted by year and then date of acquisition.

1. A Randomized Placebo-Controlled Trial of N-acetylcysteine for Cannabis Use Disorder in Adults. doc type
  Gray, Kevin M. ; Sonne, Susan C. ; McClure, Erin A. ; Ghitza, Udi E. ; Matthews, Abigail G. ; McRae-Clark, Aimee L. ; Carroll, Kathleen M. ; Potter, Jennifer Sharpe ; Wiest, Katharina ; Mooney, Larissa J. ; Hasson, Albert ; Walsh, Sharon L. ; Lofwall, Michelle R. ; Babalonis, Shanna ; Lindblad, Robert W. ; Sparenborg, Steven ; Wahle, Aimee ; King, Jacqueline S. ; Baker, Nathaniel L. ; Tomko, Rachel L. ; Haynes, Louise F. ; Vandrey, Ryan G. ; Levin, Frances R.
 Drug and Alcohol Dependence 2017;177:249-257. [doi: 10.1016/j.drugalcdep.2017.04.020].
 
2. Buprenorphine-Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study. doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Mooney, Larissa J. ; Thomas, Christie ; Ang, Alfonso ; Matthews, Abigail G. ; Hasson, Albert L. ; Annon, Jeffrey J. ; Sparenborg, Steven ; Liu, David S. ; McCormack, Jennifer ; Church, Sarah ; Swafford, William ; Drexler, Karen ; Schuman, Carolyn ; Ross, Stephen ; Wiest, Katharina L. ; Korthuis, P. Todd ; Lawson, William ; Brigham, Gregory S. ; Knox, Patricia C. ; Dawes, Michael ; Rotrosen, John
 Addiction 2016;111(8):1416-1427. [doi: 10.1111/add.13375].
 
3. Long-Term Outcomes After Randomization to Buprenorphine/Naloxone Versus Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Evans, Elizabeth ; Huang, David ; Weiss, Roger D. ; Saxon, Andrew J. ; Carroll, Kathleen M. ; Woody, George E. ; Liu, David S. ; Wakim, Paul G. ; Matthews, Abigail G. ; Hatch-Maillette, Mary A. ; Jelstrom, Eve ; Wiest, Katharina L. ; McLaughlin, Paul ; Ling, Walter
 Addiction 2016;111(4):695-705. [doi: 10.1111/add.13238].
 
4. Treatment Outcomes in Opioid Dependent Patients with Different Buprenorphine/Naloxone Induction Dosing Patterns and Trajectories. doc type
  Jacobs, Petra ; Ang, Alfonso ; Hillhouse, Maureen P. ; Saxon, Andrew J. ; Nielsen, Suzanne ; Wakim, Paul G. ; Mai, Barbara E. ; Mooney, Larissa J. ; Potter, Jennifer Sharpe ; Blaine, Jack D.
 American Journal on Addictions 2015;24:667-675. [doi: 10.1111/ajad.12288].
 
5. Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients. doc type
  Hernandez, Diana ; Feaster, Daniel J. ; Gooden, Lauren K. ; Douaihy, Antoine B. ; Mandler, Raul N. ; Erickson, Sarah J. ; Kyle, Tiffany L. ; Haynes, Louise F. ; Schwartz, Robert P. ; Das, Moupali ; Metsch, Lisa R.
 AIDS and Behavior 2016;20(1):204-214. [doi: 10.1007/s10461-015-1074-2].
 
6. Examining the Factor Structure of the Clinical Opiate Withdrawal Scale: A Secondary Data Analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003. doc type
  Barbosa-Leiker, Celestina ; McPherson, Sterling ; Mamey, Mary Rose ; Burns, G. Leonard ; Layton, Matthew E. ; Roll, John M. ; Ling, Walter
 Drug and Alcohol Dependence 2015;152:218-222. [doi: 10.1016/j.drugalcdep.2015.03.036].
 
7. Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. doc type
  Schulte, Marya T. ; Hser, Yih-Ing ; Saxon, Andrew J. ; Evans, Elizabeth ; Li, Libo ; Huang, David ; Hillhouse, Maureen P. ; Thomas, Christie ; Ling, Walter
 Journal of Community Health 2015;40(5):940-947. [doi: 10.1007/s10900-015-0016-2].
 
8. Cost-Effectiveness of Rapid Hepatitis C Virus (HCV) Testing and Simultaneous Rapid HCV and HIV Testing in Substance Abuse Treatment Programs. doc type
  Schackman, Bruce R. ; Leff, Jared A. ; Barter, Devra M. ; DiLorenzo, Madeline A. ; Feaster, Daniel J. ; Metsch, Lisa R. ; Freedberg, Kenneth A. ; Linas, Benjamin P.
 Addiction 2015;110(1):129-143. [doi: 10.1111/add.12754].
 
9. Patient Perspectives on Buprenorphine/Naloxone: A Qualitative Study of Retention During the Starting Treatment with Agonist Replacement Therapies (START) Study. doc type
  Teruya, Cheryl ; Schwartz, Robert P. ; Mitchell, Shannon G. ; Hasson, Albert L. ; Thomas, Christie ; Buoncristiani, Samantha H. ; Hser, Yih-Ing ; Wiest, Katharina ; Cohen, Allan J. ; Glick, Naomi ; Jacobs, Petra ; McLaughlin, Paul ; Ling, Walter
 Journal of Psychoactive Drugs 2014;46(5):412-426. [doi: 10.1080/02791072.2014.921743].
 
10. Achieving Cannabis Cessation -- Evaluating N-Acetylcysteine Treatment (ACCENT): Design and Implementation of a Multi-Site, Randomized Controlled Study in the National Institute on Drug Abuse Clinical Trials Network. doc type
  McClure, Erin A. ; Sonne, Susan C. ; Winhusen, Theresa M. ; Carroll, Kathleen M. ; Ghitza, Udi E. ; McRae-Clark, Aimee L. ; Matthews, Abigail G. ; Sharma, Gaurav ; VanVeldhuisen, Paul C. ; Vandrey, Ryan G. ; Levin, Frances R. ; Weiss, Roger D. ; Lindblad, Robert ; Allen, Colleen ; Mooney, Larissa J. ; Haynes, Louise F. ; Brigham, Gregory S. ; Sparenborg, Steven ; Hasson, Albert L. ; Gray, Kevin M.
 Contemporary Clinical Trials 2014;39(2):211-223. [doi: 10.1016/j.cct.2014.08.011].
 
11. HIV Risk Reduction with Buprenorphine-Naloxone or Methadone: Findings from A Randomized Trial. doc type
  Woody, George E. ; Bruce, R. Douglas ; Korthuis, P. Todd ; Chhatre, Sumedha ; Hillhouse, Maureen P. ; Jacobs, Petra ; Sorensen, James L. ; Saxon, Andrew J. ; Metzger, David S. ; Ling, Walter
 Journal of Acquired Immune Deficiency Syndromes 2014;66(3):288-293. [doi: 10.1097/QAI.0000000000000165].
 
12. Genetic Variation in OPRD1 and the Response to Treatment for Opioid Dependence with Buprenorphine in European American Females. doc type
  Clarke, Toni-Kim ; Crist, Richard C. ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade H.
 Pharmacogenomics Journal 2014;14:303-308. [doi: 10.1038/tpj.2013.30].
 
13. Treatment Retention Among Patients Randomized to Buprenorphine/Naloxone Compared to Methadone in a Multi-Site Trial. doc type
  Hser, Yih-Ing ; Saxon, Andrew J. ; Huang, David ; Hasson, Albert ; Thomas, Christie ; Hillhouse, Maureen ; Jacobs, Petra ; Teruya, Cheryl ; McLaughlin, Paul ; Wiest, Katharina ; Cohen, Allan J. ; Ling, Walter
 Addiction 2014;109(1):79-87. [doi: 10.1111/add.12333].
 
14. Induction Onto Extended-Release Naltrexone in 302 Cocaine-Dependent Opioid Users. doc type
  Lindblad, Robert ; McCormack, Jennifer ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Mooney, Larissa ; VanVeldhuisen, Paul C. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, San Diego, CA, June 15-20, 2013.
 
15. Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings from Starting Treatment with Agonist Replacement Therapies (START). doc type
  Potter, Jennifer Sharpe ; Marino, Elise N. ; Hillhouse, Maureen P. ; Nielsen, Suzanne ; Wiest, Katharina ; Canamar, Catherine P. ; Martin, Judith A. ; Ang, Alfonso ; Baker, Rachel ; Saxon, Andrew J. ; Ling, Walter
 Journal of Studies on Alcohol and Drugs 2013;74(4):605-613..
 
16. Study Endorses Onsite HIV Testing Without Risk Reduction Counseling. doc type
 
 NIDA Notes 2013;Apr 29.
 
17. An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans. doc type
  Crist, Richard C. ; Clarke, Toni-Kim ; Ang, Alfonso ; Ambrose-Lanci, Lisa ; Lohoff, Falk W. ; Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Bruce, R. Douglas ; Woody, George E. ; Berrettini, Wade
 Neuropsychopharmacology 2013;38:2003-2010. [doi: 10.1038/npp.2013.99].
 
18. A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users. doc type
  Nielsen, Suzanne ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ling, Walter
 Journal of Addiction Medicine 2013;7(1):33-38. [doi: 10.1097/ADM.0b013e318277e92e].
 
19. Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology. doc type
  Mooney, Larissa J. ; Nielsen, Suzanne ; Saxon, Andrew J. ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Stablein, Don ; McCormack, Jennifer ; Lindblad, Robert ; Ling, Walter
 Contemporary Clinical Trials 2013;34(2):196-204. [doi: 10.1016/j.cct.2012.11.002].
 
20. The Cost-Effectiveness of Rapid HIV Testing in Substance Abuse Treatment: Results of a Randomized Trial. doc type
  Schackman, Bruce R. ; Metsch, Lisa R. ; Colfax, Grant N. ; Leff, Jared A. ; Wong, Angela ; Scott, Callie A. ; Feaster, Daniel J. ; Gooden, Lauren K. ; Matheson, Tim ; Haynes, Louise F. ; Paltiel, A. David ; Walensky, Rochelle P.
 Drug and Alcohol Dependence 2013;128(1-2):90-97. [doi: 10.1016/j.drugalcdep.2012.08.009].
 
21. Buprenorphine/Naloxone and Methadone Effects on Laboratory Indices of Liver Health: A Randomized Trial. doc type doc type
  Saxon, Andrew J. ; Ling, Walter ; Hillhouse, Maureen P. ; Thomas, Christie ; Hasson, Albert ; Ang, Alfonso ; Doraimani, Geetha ; Tasissa, Gudaye ; Lokhnygina, Yuliya ; Leimberger, Jeffrey D. ; Bruce, R. Douglas ; McCarthy, John ; Wiest, Katharina ; McLaughlin, Paul ; Bilangi, Richard ; Cohen, Allan J. ; Woody, George E. ; Jacobs, Petra
 Drug and Alcohol Dependence 2013;128(1-2):71-76. [doi: 10.1016/j.drugalcdep.2012.08.002].
 
22. Item Banks for Alcohol Use from the Patient-Reported Outcomes Measurement Information System (PROMIS): Use, Consequences, and Expectancies. doc type
  Pilkonis, Paul A. ; Yu, Lan ; Colditz, Jason ; Dodds, Nathan ; Johnston, Kelly L. ; Maihoefer, Catherine ; Stover, Angela M. ; Daley, Dennis C. ; McCarty, Dennis
 Drug and Alcohol Dependence 2013;130(1-3):167-77. [doi: 10.1016/j.drugalcdep.2012.11.002].
 
23. HIV Rapid Testing in Drug Treatment: Comparison Across Treatment Modalities. doc type
  Schwartz, Robert P. ; Stitzer, Maxine L. ; Feaster, Daniel J. ; Korthuis, P. Todd ; Alvanzo, Anika A. H. ; Winhusen, Theresa M. ; Donnard, Lillian ; Snead, Ned ; Metsch, Lisa R.
 Journal of Substance Abuse Treatment 2013;44(4):369-374. [doi: 10.1016/j.jsat.2012.08.219].
 
24. Predictors of Outcome After Short-Term Stabilization with Buprenorphine. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Ling, Walter
 Journal of Substance Abuse Treatment 2013;44(1):336-342. [doi: 10.1016/j.jsat.2012.08.016].
 
25. HIV Testing History of Drug Treatment Participants in the US. doc type
  Mandler, Raul N. ; Douaihy, Antoine B. ; Feaster, Daniel J. ; Korthuis, P. Todd ; Tross, Susan ; Das, Moupali ; Saint-Jean, Gilbert ; Verdeja, Rosa ; Metsch, Lisa R. ; Colfax, Grant N.
 Poster presented at the International AIDS Society (IAS) Conference, Washington, DC, July 22-27, 2012.
 
26. Implementing Rapid HIV Testing With or Without Risk-Reduction Counseling in Drug Treatment Centers: Results of a Randomized Trial. doc type doc type
  Metsch, Lisa R. ; Feaster, Daniel J. ; Gooden, Lauren K. ; Matheson, Tim ; Mandler, Raul N. ; Haynes, Louise F. ; Tross, Susan ; Kyle, Tiffany L. ; Gallup, Dianne ; Kosinski, Andrzej S. ; Douaihy, Antoine B. ; Schackman, Bruce R. ; Das, Moupali ; Lindblad, Robert ; Erickson, Sarah J. ; Korthuis, P. Todd ; Martino, Steve ; Sorensen, James L. ; Szapocznik, Jose ; Wallensky, Rochelle ; Branson, Bernard ; Colfax, Grant N.
 American Journal of Public Health 2012;102(6):1160-1167. [doi: 10.2105/AJPH.2011.300460].
 
27. Missing Data in Substance Abuse Treatment Research: Current Methods and Modern Approaches. doc type
  McPherson, Sterling ; Barbosa-Leiker, Celestina ; Burns, G. Leonard ; Howell, Donelle ; Roll, John M.
 Experimental and Clinical Psychopharmacology 2012;20(3):243-250. [doi: 10.1037/a0027146].
 
28. Alcohol and Drug Dependence Symptom Items as Brief Screeners for Substance Use Disorders: Results from the Clinical Trials Network. doc type
  Wu, Li-Tzy ; Blazer, Dan G. ; Woody, George E. ; Burchett, Bruce ; Yang, Chongming ; Pan, Jeng-Jong ; Ling, Walter
 Journal of Psychiatric Research 2012;46(3):360-369. [doi: 10.1016/j.jpsychires.2011.12.002].
 
29. Protocol: NIDA-CTN-0027: Starting Treatment with Agonist Replacement Therapies (START). doc type
  Ling, Walter ; Saxon, Andrew J.
 Presented at the American Public Health Association (APHA) annual meeting, Washington, DC, Oct. 28 - Nov. 2, 2011.
 
30. Implementing Rapid HIV Testing With or Without Risk-Reduction Counseling in Drug Treatment Centers: Results of a Randomized Trial. doc type
  Haynes, Louise F.
 Presented at the International Society of Addiction Medicine (ISAM) annual meeting, Oslo, Norway, September 6-10, 2011.
 
31. Adoption of HIV Counseling and Testing Following Completion of Randomized Clinical Trial. doc type
  Haynes, Louise F. ; Holmes, Beverly W. ; Peay, Camille ; Metsch, Lisa R.
 Poster presented at the National HIV Prevention Conference, Atlanta, GA, August 14-17, 2011.
 
32. Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial. doc type
  Back, Sudie E. ; Payne, Rebecca ; Wahlquist, Amy Herrin ; Carter, Rickey E. ; Stroud, Zachary ; Haynes, Louise F. ; Hillhouse, Maureen P. ; Brady, Kathleen T. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):313-323. [doi: 10.3109/00952990.2011.596982].
 
33. Participant Characteristics and Buprenorphine Dose. doc type
  Hillhouse, Maureen P. ; Canamar, Catherine P. ; Doraimani, Geetha ; Thomas, Christie ; Hasson, Albert L. ; Ling, Walter
 American Journal of Drug and Alcohol Abuse 2011;37(5):453-459. [doi: 10.3109/00952990.2011.596974].
 
34. HIV Risk-Reduction: Counselor Training for a Randomized Clinical Trial. doc type
  Haynes, Louise F. ; Matheson, Tim ; Brady, Kathleen T. ; Metsch, Lisa R.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Hollywood, FL, June 21-25, 2011.
 
35. Cocaine Use Reduction with Buprenorphine (CURB: CTN-0048): Protocol Overview. doc type
  Mooney, Larissa ; Saxon, Andrew J. ; Ling, Walter
 Webinar sponsored by the NIDA Clinical Coordinating Center, May 11, 2011.
 
36. Modifying Practices in a MAT Program to the Needs of the Local Patient Population. doc type
  Wiest, Katharina ; McCarty, Dennis ; Hartnett, Timothy
 Poster presented at the American Public Health Association (APHA) Annual Meeting, Denver, CO, November 6-10, 2010.
 
37. Never HIV Tested: Results of Screening Data from 12 Drug Treatment Programs in the CTN 0032 HIV Rapid Testing and Counseling Study. doc type
  Metsch, Lisa R. ; Mandler, Raul N. ; Feaster, Daniel J. ; Gooden, Lauren K. ; Tross, Susan ; Haynes, Louise F. ; Douaihy, Antoine B. ; Das, Moupali ; Kyle, Tiffany L. ; Korthuis, P. Todd ; Schwartz, Robert P. ; Erickson, Sarah J. ; Snead, Ned ; Sorensen, James L. ; Colfax, Grant N.
 Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
38. Craving Intensity and Withdrawal Severity Across Phases of Opioid Detoxification with Buprenorphine. doc type
  Chen, Hanhui ; Hillhouse, Maureen P. ; Doraimani, Geetha ; Hasson, Albert L. ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
39. START Study Retention: Perspectives of Suboxone Dropouts. doc type
  Teruya, Cheryl ; Thomas, Christie ; Rosensteel, Anya ; Hasson, Albert L. ; Hillhouse, Maureen P. ; Hser, Yih-Ing ; Ling, Walter
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010.
 
40. Association of Race and Ethnicity with Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy. doc type
  Brown, E. Sherwood ; Tirado, Carlos F. ; Minhajuddin, Abu T. ; Hillhouse, Maureen P. ; Adinoff, Bryon H. ; Ling, Walter ; Doraimani, Geetha ; Thomas, Christie
 Journal of Ethnicity in Substance Abuse 2010;9(2):106-114. [doi: 10.1080/15332641003772587].
 
41. Feasibility of Conducting Genetics Research at Community Treatment Programs. doc type
  Sonne, Susan C. ; Gentilin, Stephanie ; Sampson, Royce ; DeVane, Lindsay ; Thomas, Christie ; Berrettini, Wade
 Poster presented at the NIDA Blending Conference, "Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings," Albuquerque, NM, April 22-23, 2010.
 
42. Research Meets Practice and Beyond: Clinical Implementation of HIV Rapid Testing. doc type
  Haynes, Louise F. ; Holmes, Beverly W.
 Presented at the CTN 10th Anniversary Symposium, Albuquerque, NM, April 21, 2010.
 
43. Gender Differences at Presentation for Treatment-Seeking Opiate Dependence. doc type
  Haynes, Louise F. ; Carter, Rickey E. ; Back, Sudie E. ; Payne, Rebecca ; Hillhouse, Maureen P.
 Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009.
 
44. Buprenorphine Tapering Schedule and Illicit Opioid Use. doc type doc type
  Ling, Walter ; Hillhouse, Maureen P. ; Domier, Catherine P. ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert L. ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard
 Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x].
 
45. Addiction Treatments of the Future: The Role of Genetics. doc type
  Kreek, Mary Jeanne ; Haynes, Louise F. ; Cohen, Allan J.
 Presented at the NIDA Blending Conference, "Blending Addiction Science & Treatment: The Impact of Evidence-Based Practices on Individuals, Families, and Communities," Cincinnati, OH, June 2-3, 2008.
 
46. Starting Treatment with Agonist Replacement Therapy: Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 Bethesda, MD: National Institute on Drug Abuse, 2006.
 
47. Using Buprenorphine in Opioid Treatment Programs. doc type
  Cohen, Allan J.
 Presented at the American Association for the Treatment of Opioid Dependence (AATOD) annual meeting, Atlanta, GA, April 2006.
 
48. Charting a Path Between Research and Practice in Alcoholism Treatment. doc type
  McCarty, Dennis ; Edmundson, Eldon Jr. ; Hartnett, Timothy
 Alcohol Research & Health 2006;29(1):5-10.
 
49. Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules. Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 

New Search